| Title | Frontiers in Clinical Drug Research - Anti Infectives |
| Abbreviation | Front. Clin. Drug Res. - Anti Infect. |
| Publication Type | Book series |
| Subject Area, Categories, Scope | Drug Discovery (Q4); Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4) |
| h-index | 1 |
| Overall Rank/Ranking | 21985 |
| SCImago Journal Rank (SJR) | 0.149 |
| Impact Score | 0.15 |
| Publisher | Bentham Science Publishers B.V. |
| Country | Netherlands |
| ISSN | 24523208, 23523212 |
| Best Quartile | Q4 |
| Coverage History | 2019-2021 |
Frontiers in Clinical Drug Research - Anti Infectives is a book series covering the technologies/fields/categories related to Drug Discovery (Q4); Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4). It is published by Bentham Science Publishers B.V.. The overall rank of Frontiers in Clinical Drug Research - Anti Infectives is 21985. According to SCImago Journal Rank (SJR), this book series is ranked 0.149. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This book series has an h-index of 1. The best quartile for this book series is Q4.
The ISSN of Frontiers in Clinical Drug Research - Anti Infectives book series is 24523208, 23523212. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Frontiers in Clinical Drug Research - Anti Infectives is cited by a total of 13 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Frontiers in Clinical Drug Research - Anti Infectives is 0.15, which is computed in 2023 as per its definition. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.15 |
| 2021 | 0.57 |
| 2020 | 0.43 |
| 2019 | 0.00 |
Frontiers in Clinical Drug Research - Anti Infectives has an h-index of 1. It means 1 articles of this book series have more than 1 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Frontiers in Clinical Drug Research - Anti Infectives is 24523208, 23523212. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Frontiers in Clinical Drug Research - Anti Infectives is 21985. According to SCImago Journal Rank (SJR), this book series is ranked 0.149. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.149 |
| 2021 | 0.359 |
| 2020 | 0.205 |
| 2019 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 21985 |
| 2021 | 13074 |
| 2020 | 19007 |
| 2019 | 30969 |
Frontiers in Clinical Drug Research - Anti Infectives is published by Bentham Science Publishers B.V.. It's publishing house is located in Netherlands. Coverage history of this book series is as following: 2019-2021. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Frontiers in Clinical Drug Research - Anti Infectives is Front. Clin. Drug Res. - Anti Infect.. This abbreviation ('Front. Clin. Drug Res. - Anti Infect.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Drug Discovery (Q4); Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4), then please visit the official website of this book series.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Frontiers in Clinical Drug Research - Anti Infectives latest impact IF is 0.15. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this book series are 0.57 (2021) and 0.00 (2019), respectively, in the last 4 years. Moreover, its average IS is 0.29 in the previous 4 years.
The Frontiers in Clinical Drug Research - Anti Infectives has an SJR (SCImago Journal Rank) of 0.149, according to the latest data. It is computed in the year 2023. In the past 4 years, this book series has recorded a range of SJR, with the highest being 0.359 in 2021 and the lowest being in 2019. Furthermore, the average SJR of the Frontiers in Clinical Drug Research - Anti Infectives over the previous 4-year period stands at 0.29.
The latest h-index of the Frontiers in Clinical Drug Research - Anti Infectives is 1.
The Frontiers in Clinical Drug Research - Anti Infectives is published by the Bentham Science Publishers B.V., with its country of publication being the Netherlands.
The Frontiers in Clinical Drug Research - Anti Infectives is currently ranked 21985 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 4 years, this book series has experienced varying rankings, reaching its highest position of 13074 in 2021 and its lowest position of 30969 in 2019.
The standard ISO4 abbreviation for the Frontiers in Clinical Drug Research - Anti Infectives is Front. Clin. Drug Res. - Anti Infect..
Frontiers in Clinical Drug Research - Anti Infectives is classified as a book series that the Bentham Science Publishers B.V. publishes.
The Frontiers in Clinical Drug Research - Anti Infectives encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this book series.
The Frontiers in Clinical Drug Research - Anti Infectives is assigned the following International Standard Serial Numbers (ISSN): 24523208, 23523212.
The best quartile for the Frontiers in Clinical Drug Research - Anti Infectives is Q4 (2022).
The Frontiers in Clinical Drug Research - Anti Infectives coverage history can be summarized as follows: 2019-2021.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Zeitschrift fur Germanistische Linguistik | journal | 22945 | De Gruyter Mouton | 15 | 0.19 |
| Historia | journal | 27560 | Universidade Estadual Paulista | 7 | 0.02 |
| Proceedings of the ASME Turbo Expo | conference and proceedings | 17577 | 54 | 0.00 | |
| Istanbul University - Journal of Electrical and Electronics Engineering | journal | 24654 | University of Istanbul | 0 | 0.00 |
| Milan Journal of Mathematics | journal | 3120 | Birkhauser Verlag Basel | 28 | 1.79 |
| European Journal of Education | journal | 6079 | Wiley-Blackwell Publishing Ltd | 53 | 2.31 |
| Syntax | journal | 3422 | Wiley-Blackwell Publishing Ltd | 29 | 0.93 |
| Biological Procedures Online | journal | 3350 | BioMed Central Ltd. | 43 | 6.40 |
| Journal des Professionnels de l'Enfance | journal | 27577 | TPMA | 2 | 0.00 |
| European Journal of Cancer, Supplement | journal | 9063 | Elsevier Ltd. | 28 | 1.93 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.15 |
| 2021 | 0.57 |
| 2020 | 0.43 |
| 2019 | 0.00 |
